Trade SKYE anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Skye Bioscience, Inc. (SKYE) is trading at US$1.86, down 4.87% today as of Aug 28, 12:18 EDT. The company has a market capitalisation of US$1.24M. Over the past 52 weeks, SKYE has traded between US$1.84 and US$39.92. On Syfe you can trade SKYE with $0 commission and add it to your watchlist.
| Previous close | US$1.95 |
|---|---|
| Market cap | US$1.24M |
| 52-week range | US$1.84 – US$39.92 |
| Volume | 50.61K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Skye Bioscience, Inc.
Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.
Year: 2014
Skye Bioscience, Inc. (SKYE) stock is trading at US$1.86, -4.87% from the previous close of US$1.95.
The market cap for Skye Bioscience, Inc. (SKYE) stock is approximately US$1.24M.
The 52-week high for Skye Bioscience, Inc. (SKYE) stock is US$39.92.
The 52-week low for Skye Bioscience, Inc. (SKYE) stock is US$1.84.
Skye Bioscience, Inc. (SKYE) does not currently pay a dividend.
Stay on top of SKYE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
